Herold Co-Edits New Book on Cancer DiagnosticsFischell Department of Bioengineering (BioE) associate professor Keith Herold is the co-editor of a new book on the use of biosensors for cancer diagnostics, part of the "Series In Sensors" produced by CRC Press. Avraham Rasooly (National Cancer Institute, FDA) is Herold’s co-editor.
Biosensors and Molecular Technologies for Cancer Diagnostics explores the latest alternatives to standard methods of genomic and proteomic cancer detection. The book's goal is to bridge a gap between current research and clinical application, and to make biosensor technology—which is poised to provide faster screening and earlier diagnoses—more accessible to oncologists, pathologists, engineers and molecular biologists.
The book covers major areas of biosensor technology and functionality, including optical technologies (such as surface plasmon resonance, evanescent wave, spectrometry, fluorescence, and photoacoustic), electrochemical detection, electronic and magnetic technologies, thermoelectric sensing, and cantilever-based technologies.
For More Information:
See Biosensors and Molecular Technologies for Cancer Diagnostics on the CRC Pess web site »
Published October 2, 2012